Close Menu

Books in a Library

lamivudine

A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy

Issue: 
DOI: 
10.7727/wimj.2014.066
Pages: 
291–3

ABSTRACT

Accepted: 
14 Apr, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 14 Jul, 2015

Investigation by the Method of INNO-LiPA of Primary Resistance to Lamivudine in Patients with Chronic Hepatitis B Who Have Not Used Antiviral Therapy

Issue: 
DOI: 
10.7727/wimj.2014.291
Pages: 
111–5
Synopsis: 
Lamivudine, an effective oral antiviral agent, inhibits the replication of hepatitis B virus by blocking reverse transcriptase enzyme. Administering lamivudine is an effective and convenient method of early treatment.

ABSTRACT

Accepted: 
29 Oct, 2014
PDF Attachment: 
Journal Sections: 
e-Published: 30 Apr, 2015

A Simplified HAART Regimen with Raltegravir and Lamivudine, and Pharmacokinetic Interactions with a Combined Immunosuppressive Therapy with Tacrolimus and Everolimus in an HIV/HCV/HBV/HDV Patient after Liver Transplantation

Issue: 
DOI: 
10.7727/wimj.2013.264
Pages: 
779–84

ABSTRACT

Accepted: 
28 Nov, 2013
PDF Attachment: 
Journal Sections: 
e-Published: 03 Sep, 2014
Subscribe to RSS - lamivudine
Top of Page